4.7M
XNAS Volume
High volume+gain today
XNAS 21 Mar, 2025 5:30 PM (EDT)
Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 04 Mar 2025 | 10,366 | 890,409 (4%) | 0% | 0.4 | 4,561 | Common Stock |
Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 04 Mar 2025 | 14,502 | 390,459 (2%) | 0% | 0.4 | 6,381 | Common Stock |
Constantine Chinoporos | See Remarks | Sale of securities on an exchange or to another person at price $ 0.44 per share. | 04 Mar 2025 | 447 | 271,436 (1%) | 0% | 0.4 | 197 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 06 Feb 2025 | 86,078 | 900,775 (4%) | 0% | 0.6 | 52,508 | Common Stock |
Les Funtleyder | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 06 Feb 2025 | 22,950 | 404,961 (2%) | 0% | 0.6 | 14,000 | Common Stock |
Constantine Chinoporos | See Remarks | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 06 Feb 2025 | 28,117 | 271,883 (1%) | 0% | 0.6 | 17,151 | Common Stock |
Les Funtleyder | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
Funtleyder Les | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Dec 2024 | 150,000 | 427,911 (2%) | 0% | 0 | Common Stock | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.83 per share. | 22 Aug 2024 | 22,681 | 986,853 (5%) | 0% | 5.8 | 132,230 | Common Stock |
Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.83 per share. | 22 Aug 2024 | 13,530 | 277,911 (1%) | 0% | 5.8 | 78,880 | Common Stock |
Shoshana Shendelman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2024 | 747,886 | 747,886 (4%) | 4% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 05 Aug 2024 | 747,886 | 0 (0%) | 4% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.93 per share. | 05 Aug 2024 | 119,591 | 4,690,839 (25%) | 0% | 5.9 | 709,175 | Common Stock |
Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 6.18 per share. | 05 Aug 2024 | 357,423 | 4,810,430 (25%) | 1% | 6.2 | 2,208,874 | Common Stock |
Shoshana Shendelman | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 05 Aug 2024 | 300,000 | 5,167,853 (27%) | 1% | 6.0 | 1,794,000 | Common Stock |
Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 65,000 (0%) | 0% | 0 | Common Stock | |
Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 498,414 (2%) | 0% | 0 | Common Stock | |
Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 108,000 (0%) | 0% | 0 | Common Stock | |
Teena Lerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 45,000 | 105,422 (0%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 61,795 | 3,756,019 (20%) | 0% | 4.3 | 266,954 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 22,003 | 1,009,534 (5%) | 0% | 4.3 | 95,053 | Common Stock |
Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.32 per share. | 06 Jun 2024 | 16,980 | 291,441 (1%) | 0% | 4.3 | 73,354 | Common Stock |
Corwin Dale Hooks | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2024 | 300,000 | 300,000 (1%) | 1% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 318,573 | 3,817,814 (20%) | 1% | 5.4 | 1,717,108 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 110,804 | 1,031,537 (5%) | 0% | 5.4 | 597,234 | Common Stock |
Les Funtleyder | Director, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 28,727 | 308,421 (1%) | 0% | 5.4 | 154,839 | Common Stock |
Adam Hansard | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 5.39 per share. | 14 Mar 2024 | 48,871 | 732,919 (3%) | 0% | 5.4 | 263,415 | Common Stock |
Constantine Chinoporos | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Dec 2023 | 300,000 | 300,000 (1%) | 1% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 440,000 | 4,136,387 (22%) | 2% | 0 | Common Stock | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 450,000 | 1,142,341 (6%) | 2% | 0 | Common Stock | |
Shendelman Shoshana | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 1,100,000 | 3,696,387 (19%) | 5% | 0 | Common Stock | |
Hansard Adam | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Dec 2023 | 400,000 | 781,790 (4%) | 2% | 0 | Common Stock | |
Kanter Stacy J. | Director | Purchase of securities on an exchange or from another person at price $ 2.18 per share. | 01 Dec 2023 | 30,000 | 63,000 (0%) | 0% | 2.2 | 65,367 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 30 Nov 2023 | 3,968 | 2,596,387 (14%) | 0% | 2.0 | 7,817 | Common Stock |
Adam Hansard | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 1.97 per share. | 30 Nov 2023 | 965 | 381,790 (2%) | 0% | 2.0 | 1,901 | Common Stock |
Les Funtleyder | Director, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 300,000 | 337,148 (1%) | 1% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 27 Sep 2023 | 115,632 | 2,600,355 (14%) | 0% | 2.7 | 312,206 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 27 Sep 2023 | 10,932 | 693,924 (3%) | 0% | 2.7 | 29,516 | Common Stock |
Adam Hansard | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 2.70 per share. | 27 Sep 2023 | 9,720 | 382,755 (2%) | 0% | 2.7 | 26,244 | Common Stock |
Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2023 | 12,375 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.05 per share. | 15 Sep 2023 | 12,375 | 453,414 (2%) | 0% | 1.1 | 12,994 | Common Stock |
Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 20,000 (0%) | 0% | 0 | Common Stock | |
Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 441,039 (2%) | 0% | 0 | Common Stock | |
Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 37,148 (0%) | 0% | 0 | Common Stock | |
Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 33,000 (0%) | 0% | 0 | Common Stock | |
Teena Lerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 20,000 | 60,422 (0%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 11 Jan 2023 | 15,870 | 751,625 (4%) | 0% | 0.9 | 14,442 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 1,964,362 | 2,715,987 (14%) | 10% | 0 | Common Stock | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 550,000 | 704,856 (3%) | 2% | 0 | Common Stock | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 11 Jan 2023 | 6,053 | 154,856 (0%) | 0% | 0.9 | 5,508 | Common Stock |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2023 | 300,000 | 392,475 (2%) | 1% | 0 | Common Stock | |
Adam Hansard | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 0.91 per share. | 11 Jan 2023 | 4,495 | 92,475 (0%) | 0% | 0.9 | 4,090 | Common Stock |
Steven Ortega | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Nov 2022 | 40,000 | 55,404 (0%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 14 Oct 2022 | 50,000 | 767,495 (4%) | 0% | 0.6 | 32,250 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.56 per share. | 13 Oct 2022 | 73,256 | 717,495 (3%) | 0% | 0.6 | 40,891 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.52 per share. | 12 Oct 2022 | 38,153 | 644,239 (3%) | 0% | 0.5 | 19,943 | Common Stock |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,389 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,389 | 7,389 | - | - | Employee Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 8,824 | 8,824 | - | - | Employee Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 8,824 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,264 | 7,264 | - | - | Employee Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 7,264 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 19,058 | 19,058 | - | - | Employee Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 19,058 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 23,317 | 23,317 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 234,616 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 234,616 | 234,616 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 101,670 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 101,670 | 101,670 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,979 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,979 | 134,979 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 23,317 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 607,484 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 607,484 | 607,484 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 36,495 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,997 | 134,997 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 50,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 32,100 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 32,100 | 32,100 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 32,100 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 32,100 | 32,100 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 134,997 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 51,666 | 51,666 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 51,666 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 36,495 | 36,495 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 20,460 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 20,460 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 10,230 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 10,230 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Teena Lerner | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 16,500 | 16,500 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 32,339 | 32,339 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 50,000 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 21,100 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 21,100 | 21,100 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 21,100 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 21,100 | 21,100 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 32,339 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 104,665 | 0 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 02 Aug 2022 | 104,665 | 104,665 | - | - | Employee Stock Option (Right to Buy) | |
Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Teena Lerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2022 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Sale of securities on an exchange or to another person at price $ 1.65 per share. | 16 May 2022 | 905 | 9,800 (0%) | 0% | 1.6 | 1,493 | Common Stock |
Chids Mahadevan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 19,058 | 19,058 | - | - | Employee Stock Option (Right to Buy) | |
Chids Mahadevan | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 2,136 | 10,705 (0%) | 0% | 0 | Common Stock | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 50,000 | 50,000 | - | - | Employee Stock Option (Right to Buy) | |
Steven Ortega | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 10,675 | 10,675 | - | - | Employee Stock Option (Right to Buy) | |
Steven Ortega | Principal Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2022 | 3,081 | 15,404 (0%) | 0% | 0 | Common Stock | |
Riccardo Perfetti | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.85 per share. | 21 Mar 2022 | 12,548 | 108,948 (0%) | 0% | 1.9 | 23,214 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.97 per share. | 21 Mar 2022 | 30,000 | 160,909 (0%) | 0% | 2.0 | 59,100 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.98 per share. | 21 Mar 2022 | 21,961 | 130,909 (0%) | 0% | 2.0 | 43,483 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jan 2022 | 234,616 | 234,616 | - | - | Employee Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 120,900 | 606,086 (3%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 80,600 | 80,600 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 32,100 | 32,100 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 48,200 | 96,400 (0%) | 0% | 0 | Common Stock | |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 21,100 | 21,100 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 31,700 | 96,970 (0%) | 0% | 0 | Common Stock | |
Charles Silberstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 32,000 | 32,000 | - | - | Employee Stock Option (Right to Buy) | |
Charles Silberstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 47,900 | 183,603 (0%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 120,900 | 485,186 (2%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 80,600 | 80,600 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 32,100 | 32,100 | - | - | Employee Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 48,200 | 48,200 (0%) | 0% | 0 | Common Stock | |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 21,100 | 21,100 | - | - | Employee Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 31,700 | 65,270 (0%) | 0% | 0 | Common Stock | |
Charles Silberstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 32,000 | 32,000 | - | - | Employee Stock Option (Right to Buy) | |
Charles Silberstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Dec 2021 | 47,900 | 135,703 (0%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.49 per share. | 13 Sep 2021 | 9,300 | 364,286 (1%) | 0% | 14.5 | 134,740 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 14.69 per share. | 13 Sep 2021 | 701 | 354,986 (1%) | 0% | 14.7 | 10,298 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.18 per share. | 09 Aug 2021 | 10,300 | 4,700 (0%) | 0% | 17.2 | 176,954 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 8,873 | 94,874 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 15,000 | 103,747 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.35 per share. | 09 Aug 2021 | 800 | 0 (0%) | 0% | 16.4 | 13,080 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 15.85 per share. | 09 Aug 2021 | 8,273 | 600 (0%) | 0% | 15.8 | 131,127 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 09 Aug 2021 | 8,873 | 8,873 (0%) | 0% | 1.4 | 12,777 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 09 Aug 2021 | 4,700 | 0 (0%) | 0% | 17.9 | 83,895 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 09 Aug 2021 | 15,000 | 15,000 (0%) | 0% | 1.4 | 21,600 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.39 per share. | 27 Jul 2021 | 7,224 | 0 (0%) | 0% | 17.4 | 125,625 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 15,000 | 118,747 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 15,000 | 133,747 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2021 | 15,000 | 148,747 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.18 per share. | 27 Jul 2021 | 15,000 | 0 (0%) | 0% | 17.2 | 257,700 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 27 Jul 2021 | 15,000 | 15,000 (0%) | 0% | 1.4 | 21,600 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.50 per share. | 27 Jul 2021 | 15,000 | 0 (0%) | 0% | 17.5 | 262,500 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 27 Jul 2021 | 15,000 | 15,000 (0%) | 0% | 1.4 | 21,600 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.05 per share. | 27 Jul 2021 | 7,776 | 7,224 (0%) | 0% | 17.1 | 132,581 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 27 Jul 2021 | 15,000 | 15,000 (0%) | 0% | 1.4 | 21,600 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 460 | 164,667 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.54 per share. | 13 Jul 2021 | 460 | 0 (0%) | 0% | 19.5 | 8,988 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 13 Jul 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.51 per share. | 13 Jul 2021 | 460 | 0 (0%) | 0% | 20.5 | 9,435 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 13 Jul 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.25 per share. | 13 Jul 2021 | 460 | 0 (0%) | 0% | 21.3 | 9,775 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 13 Jul 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 460 | 163,747 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2021 | 460 | 164,207 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.01 per share. | 28 Jun 2021 | 1,200 | 0 (0%) | 0% | 24.0 | 28,812 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.51 per share. | 28 Jun 2021 | 1,987 | 1,200 (0%) | 0% | 23.5 | 46,714 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.96 per share. | 28 Jun 2021 | 360 | 3,187 (0%) | 0% | 22.0 | 7,906 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 Jun 2021 | 3,547 | 3,547 (0%) | 0% | 1.4 | 5,108 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 460 | 165,127 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 460 | 165,587 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jun 2021 | 3,547 | 166,047 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.71 per share. | 28 Jun 2021 | 300 | 0 (0%) | 0% | 21.7 | 6,513 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.80 per share. | 28 Jun 2021 | 160 | 300 (0%) | 0% | 20.8 | 3,328 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 Jun 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.76 per share. | 28 Jun 2021 | 460 | 0 (0%) | 0% | 21.8 | 10,010 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 Jun 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Charles Silberstein | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.42 per share. | 08 Jun 2021 | 5,047 | 87,803 (0%) | 0% | 21.4 | 108,107 | Common Stock |
Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 460 | 170,054 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 460 | 170,514 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 03 Jun 2021 | 260 | 0 (0%) | 0% | 21.4 | 5,559 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.43 per share. | 03 Jun 2021 | 200 | 260 (0%) | 0% | 20.4 | 4,086 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 03 Jun 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.65 per share. | 03 Jun 2021 | 460 | 0 (0%) | 0% | 19.7 | 9,039 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 03 Jun 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.66 per share. | 03 Jun 2021 | 460 | 0 (0%) | 0% | 19.7 | 9,044 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jun 2021 | 460 | 169,594 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 03 Jun 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Teena Lerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2021 | 16,500 | 16,500 | - | - | Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 18.35 per share. | 26 May 2021 | 2,894 | 33,570 (0%) | 0% | 18.4 | 53,105 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 1,640 | 171,894 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.43 per share. | 24 May 2021 | 460 | 0 (0%) | 0% | 19.4 | 8,938 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 24 May 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.97 per share. | 24 May 2021 | 460 | 0 (0%) | 0% | 18.0 | 8,266 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 24 May 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 24 May 2021 | 1,640 | 1,640 (0%) | 0% | 1.4 | 2,362 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.25 per share. | 24 May 2021 | 1,640 | 0 (0%) | 0% | 17.3 | 28,290 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 460 | 170,974 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2021 | 460 | 171,434 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.27 per share. | 11 May 2021 | 200 | 0 (0%) | 0% | 17.3 | 3,454 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 May 2021 | 200 | 173,534 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 11 May 2021 | 200 | 200 (0%) | 0% | 1.4 | 288 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.68 per share. | 26 Mar 2021 | 465 | 0 (0%) | 0% | 19.7 | 9,151 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2021 | 460 | 176,494 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2021 | 465 | 176,954 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Mar 2021 | 465 | 177,419 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.43 per share. | 26 Mar 2021 | 460 | 0 (0%) | 0% | 18.4 | 8,478 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 26 Mar 2021 | 460 | 460 (0%) | 0% | 1.4 | 662 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.53 per share. | 26 Mar 2021 | 465 | 0 (0%) | 0% | 18.5 | 8,616 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 26 Mar 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 26 Mar 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.48 per share. | 11 Mar 2021 | 465 | 0 (0%) | 0% | 18.5 | 8,593 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 465 | 177,884 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 465 | 178,349 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2021 | 465 | 178,814 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.61 per share. | 11 Mar 2021 | 465 | 0 (0%) | 0% | 19.6 | 9,119 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 11 Mar 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.38 per share. | 11 Mar 2021 | 465 | 0 (0%) | 0% | 19.4 | 9,012 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 11 Mar 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 11 Mar 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 23 Feb 2021 | 1,295 | 1,295 (0%) | 0% | 1.4 | 1,865 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 1,295 | 179,279 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 2,125 | 180,574 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2021 | 465 | 182,669 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.20 per share. | 23 Feb 2021 | 1,295 | 0 (0%) | 0% | 23.2 | 30,044 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.57 per share. | 23 Feb 2021 | 600 | 0 (0%) | 0% | 24.6 | 14,742 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.71 per share. | 23 Feb 2021 | 1,525 | 600 (0%) | 0% | 23.7 | 36,158 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 23 Feb 2021 | 2,125 | 2,125 (0%) | 0% | 1.4 | 3,060 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.84 per share. | 23 Feb 2021 | 465 | 0 (0%) | 0% | 21.8 | 10,156 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 23 Feb 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Stacy J. Kanter | Director | Purchase of securities on an exchange or from another person at price $ 22.86 per share. | 19 Feb 2021 | 6,500 | 13,000 (0%) | 0% | 22.9 | 148,590 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 1,295 | 183,164 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 1,295 | 184,459 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 3,785 | 185,754 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 27.30 per share. | 01 Feb 2021 | 600 | 0 (0%) | 0% | 27.3 | 16,380 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.35 per share. | 01 Feb 2021 | 695 | 600 (0%) | 0% | 26.3 | 18,313 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 01 Feb 2021 | 1,295 | 1,295 (0%) | 0% | 1.4 | 1,865 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 27.77 per share. | 01 Feb 2021 | 595 | 0 (0%) | 0% | 27.8 | 16,523 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.87 per share. | 01 Feb 2021 | 700 | 595 (0%) | 0% | 26.9 | 18,809 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 01 Feb 2021 | 1,295 | 1,295 (0%) | 0% | 1.4 | 1,865 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.43 per share. | 01 Feb 2021 | 660 | 0 (0%) | 0% | 26.4 | 17,444 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.47 per share. | 01 Feb 2021 | 2,325 | 660 (0%) | 0% | 25.5 | 59,218 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 01 Feb 2021 | 3,785 | 3,785 (0%) | 0% | 1.4 | 5,450 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.36 per share. | 01 Feb 2021 | 800 | 2,985 (0%) | 0% | 24.4 | 19,488 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.83 per share. | 19 Jan 2021 | 465 | 0 (0%) | 0% | 21.8 | 10,151 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 465 | 189,539 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 465 | 189,004 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Jan 2021 | 465 | 189,469 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 19 Jan 2021 | 465 | 0 (0%) | 0% | 20.3 | 9,440 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 19 Jan 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.08 per share. | 19 Jan 2021 | 465 | 0 (0%) | 0% | 21.1 | 9,802 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 19 Jan 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 19 Jan 2021 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.50 per share. | 06 Jan 2021 | 7,600 | 0 (0%) | 0% | 23.5 | 178,600 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 7,985 | 189,934 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 765 | 197,919 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 7,765 | 198,684 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.18 per share. | 06 Jan 2021 | 7,685 | 0 (0%) | 0% | 23.2 | 178,138 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.92 per share. | 06 Jan 2021 | 300 | 7,685 (0%) | 0% | 21.9 | 6,576 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 06 Jan 2021 | 7,765 | 7,765 (0%) | 0% | 1.4 | 11,182 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 06 Jan 2021 | 7,985 | 7,985 (0%) | 0% | 1.4 | 11,498 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.88 per share. | 06 Jan 2021 | 765 | 0 (0%) | 0% | 21.9 | 16,738 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 06 Jan 2021 | 765 | 765 (0%) | 0% | 1.4 | 1,102 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 22.17 per share. | 06 Jan 2021 | 165 | 7,600 (0%) | 0% | 22.2 | 3,658 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 Dec 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 465 | 206,449 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 465 | 206,914 | - | - | Stock Option (Right to Buy | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2020 | 465 | 207,379 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.68 per share. | 28 Dec 2020 | 65 | 0 (0%) | 0% | 21.7 | 1,409 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.97 per share. | 28 Dec 2020 | 400 | 65 (0%) | 0% | 21.0 | 8,388 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 Dec 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.95 per share. | 28 Dec 2020 | 465 | 0 (0%) | 0% | 22.0 | 10,207 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 Dec 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.81 per share. | 28 Dec 2020 | 465 | 0 (0%) | 0% | 21.8 | 10,142 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 256,850 | 256,850 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 92,200 | 92,200 | - | - | Stock Option (Right to Buy) | |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 81,700 | 81,700 | - | - | Stock Option (Right to Buy) | |
Charles Silberstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Dec 2020 | 92,850 | 92,850 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.49 per share. | 07 Dec 2020 | 465 | 0 (0%) | 0% | 20.5 | 9,528 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 465 | 207,844 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 465 | 208,309 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Dec 2020 | 465 | 208,774 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.46 per share. | 07 Dec 2020 | 465 | 0 (0%) | 0% | 20.5 | 9,514 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Dec 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.98 per share. | 07 Dec 2020 | 465 | 0 (0%) | 0% | 20.0 | 9,291 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Dec 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Dec 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.68 per share. | 20 Nov 2020 | 900 | 760 (0%) | 0% | 18.7 | 16,812 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 465 | 209,239 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 465 | 209,704 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2020 | 1,660 | 210,169 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.62 per share. | 20 Nov 2020 | 465 | 0 (0%) | 0% | 21.6 | 10,053 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Nov 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 20.59 per share. | 20 Nov 2020 | 465 | 0 (0%) | 0% | 20.6 | 9,574 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Nov 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.54 per share. | 20 Nov 2020 | 760 | 0 (0%) | 0% | 19.5 | 14,850 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Nov 2020 | 1,660 | 1,660 (0%) | 0% | 1.4 | 2,390 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.59 per share. | 10 Nov 2020 | 200 | 0 (0%) | 0% | 17.6 | 3,518 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Nov 2020 | 200 | 211,829 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 10 Nov 2020 | 200 | 200 (0%) | 0% | 1.4 | 288 | Common Stock |
Joel S. Marcus | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 29 Oct 2020 | 50,000 | 315,360 (1%) | 0% | 0 | Common Stock | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2020 | 465 | 212,029 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2020 | 465 | 212,494 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Oct 2020 | 465 | 212,959 | - | - | Stock Option (Right to Buy) | |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.27 per share. | 27 Oct 2020 | 465 | 0 (0%) | 0% | 17.3 | 8,031 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 27 Oct 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.49 per share. | 27 Oct 2020 | 465 | 0 (0%) | 0% | 18.5 | 8,598 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 27 Oct 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 21.20 per share. | 27 Oct 2020 | 465 | 0 (0%) | 0% | 21.2 | 9,858 | Common Stock |
Riccardo Perfetti | Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 27 Oct 2020 | 465 | 465 (0%) | 0% | 1.4 | 670 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2020 | 30,000 | 40,502 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.07 per share. | 01 Oct 2020 | 5,976 | 17,148 (0%) | 0% | 20.1 | 119,938 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.75 per share. | 01 Oct 2020 | 1,353 | 23,124 (0%) | 0% | 20.8 | 28,075 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 01 Oct 2020 | 22,671 | 24,477 (0%) | 0% | 20.0 | 454,100 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 01 Oct 2020 | 30,000 | 47,148 (0%) | 0% | 4.7 | 141,000 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Aug 2020 | 20,000 | 70,502 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 24.18 per share. | 21 Aug 2020 | 6,461 | 17,148 (0%) | 0% | 24.2 | 156,227 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 23.42 per share. | 21 Aug 2020 | 13,539 | 23,609 (0%) | 0% | 23.4 | 317,083 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 21 Aug 2020 | 20,000 | 37,148 (0%) | 0% | 4.7 | 94,000 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.19 per share. | 20 Jul 2020 | 12,100 | 557,185 (3%) | 0% | 27.2 | 328,999 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 539,609 | - | - | Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 554,609 | - | - | Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jul 2020 | 15,000 | 569,609 | - | - | Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.51 per share. | 20 Jul 2020 | 2,949 | 554,285 (2%) | 0% | 26.5 | 78,178 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 25.45 per share. | 20 Jul 2020 | 12,051 | 557,235 (3%) | 0% | 25.5 | 306,698 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.24 per share. | 20 Jul 2020 | 100 | 554,285 (2%) | 0% | 28.2 | 2,824 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.42 per share. | 20 Jul 2020 | 7,300 | 554,385 (2%) | 0% | 27.4 | 200,166 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 26.69 per share. | 20 Jul 2020 | 7,600 | 561,685 (3%) | 0% | 26.7 | 202,844 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 20 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 20 Jul 2020 | 300 | 554,285 (2%) | 0% | 28.6 | 8,592 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 27.88 per share. | 20 Jul 2020 | 2,600 | 554,585 (2%) | 0% | 27.9 | 72,488 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.63 per share. | 07 Jul 2020 | 1,995 | 567,290 (3%) | 0% | 31.6 | 63,102 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.25 per share. | 07 Jul 2020 | 13,005 | 554,285 (2%) | 0% | 32.2 | 419,411 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 07 Jul 2020 | 15,000 | 569,285 (3%) | 0% | 1.4 | 21,600 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.21 per share. | 07 Jul 2020 | 12,889 | 556,396 (3%) | 0% | 32.2 | 415,155 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 32.98 per share. | 07 Jul 2020 | 2,111 | 554,285 (2%) | 0% | 33.0 | 69,621 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 30.90 per share. | 07 Jul 2020 | 10,936 | 558,349 (3%) | 0% | 30.9 | 337,922 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 31.64 per share. | 07 Jul 2020 | 4,064 | 554,285 (2%) | 0% | 31.6 | 128,585 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2020 | 15,000 | 614,605 | - | - | Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2020 | 15,000 | 599,605 | - | - | Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jul 2020 | 15,000 | 584,605 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 43.32 per share. | 23 Jun 2020 | 4,629 | 32,519 (0%) | 0% | 43.3 | 200,528 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 38.28 per share. | 23 Jun 2020 | 100 | 17,148 (0%) | 0% | 38.3 | 3,828 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 37.52 per share. | 23 Jun 2020 | 517 | 17,248 (0%) | 0% | 37.5 | 19,398 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 36.12 per share. | 23 Jun 2020 | 200 | 17,765 (0%) | 0% | 36.1 | 7,224 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 40.92 per share. | 23 Jun 2020 | 400 | 17,965 (0%) | 0% | 40.9 | 16,368 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 40.41 per share. | 23 Jun 2020 | 3,811 | 18,365 (0%) | 0% | 40.4 | 154,003 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 39.20 per share. | 23 Jun 2020 | 3,572 | 22,176 (0%) | 0% | 39.2 | 140,022 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 47.40 per share. | 23 Jun 2020 | 1,340 | 25,748 (0%) | 0% | 47.4 | 63,516 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 46.45 per share. | 23 Jun 2020 | 160 | 27,088 (0%) | 0% | 46.5 | 7,432 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.35 per share. | 23 Jun 2020 | 1,809 | 27,248 (0%) | 0% | 45.3 | 82,038 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.54 per share. | 23 Jun 2020 | 3,462 | 29,057 (0%) | 0% | 44.5 | 154,197 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.91 per share. | 18 Jun 2020 | 11 | 17,148 (0%) | 0% | 45.9 | 505 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2020 | 20,000 | 90,502 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 18 Jun 2020 | 20,000 | 37,148 (0%) | 0% | 4.7 | 94,000 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.32 per share. | 18 Jun 2020 | 7,487 | 17,159 (0%) | 0% | 45.3 | 339,311 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.37 per share. | 15 Jun 2020 | 5,302 | 28,846 (0%) | 0% | 44.4 | 235,250 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jun 2020 | 17,000 | 110,502 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.15 per share. | 15 Jun 2020 | 4,100 | 24,646 (0%) | 0% | 44.2 | 181,015 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.18 per share. | 15 Jun 2020 | 100 | 28,746 (0%) | 0% | 45.2 | 4,518 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 15 Jun 2020 | 17,000 | 34,148 (0%) | 0% | 4.7 | 79,900 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.77 per share. | 08 Jun 2020 | 8,315 | 25,833 (0%) | 0% | 44.8 | 372,263 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jun 2020 | 17,000 | 127,502 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 42.83 per share. | 08 Jun 2020 | 2,563 | 17,148 (0%) | 0% | 42.8 | 109,773 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 41.80 per share. | 08 Jun 2020 | 2,622 | 19,711 (0%) | 0% | 41.8 | 109,600 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.87 per share. | 08 Jun 2020 | 1,500 | 22,333 (0%) | 0% | 44.9 | 67,305 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 42.82 per share. | 08 Jun 2020 | 2,000 | 23,833 (0%) | 0% | 42.8 | 85,640 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 08 Jun 2020 | 17,000 | 34,148 (0%) | 0% | 4.7 | 79,900 | Common Stock |
Jay S. Skyler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 10,230 | 10,230 | - | - | Stock Option (Right to Buy) | |
Joel S. Marcus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 10,230 | 10,230 | - | - | Stock Option (Right to Buy) | |
Stacy J. Kanter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 10,230 | 10,230 | - | - | Stock Option (Right to Buy) | |
Teena Lerner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 10,230 | 10,230 | - | - | Stock Option (Right to Buy) | |
Charles Silberstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 183,000 | 183,000 | - | - | Employee Stock Option (Right to Buy) | |
Charles Silberstein | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2020 | 61,000 | 61,000 (0%) | 0% | 0 | Common Stock | |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 02 Jun 2020 | 15,000 | 32,148 (0%) | 0% | 4.7 | 70,500 | Common Stock |
Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2020 | 10,230 | 10,230 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2020 | 15,000 | 144,502 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.17 per share. | 02 Jun 2020 | 1,482 | 17,148 (0%) | 0% | 44.2 | 65,460 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.03 per share. | 02 Jun 2020 | 1,032 | 18,630 (0%) | 0% | 44.0 | 45,439 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.21 per share. | 02 Jun 2020 | 12,486 | 19,662 (0%) | 0% | 45.2 | 564,492 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 290,280 | 3,014,005 (16%) | 1% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.44 per share. | 28 May 2020 | 97,376 | 679,285 (3%) | 0% | 1.4 | 140,221 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 28 May 2020 | 27,624 | 581,909 (3%) | 0% | 1 | 27,624 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 709,720 | 709,720 (3%) | 3% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 290,280 | 290,280 (1%) | 1% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 May 2020 | 709,720 | 2,304,285 (12%) | 3% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 97,376 | 629,605 | - | - | Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 27,624 | 0 | - | - | Stock Option (Right to Buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 42.70 per share. | 28 May 2020 | 125,000 | 554,285 (2%) | 0% | 42.7 | 5,337,500 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 44.27 per share. | 28 May 2020 | 7,120 | 25,643 (0%) | 0% | 44.3 | 315,202 | Common Stock |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 48.27 per share. | 28 May 2020 | 2,838 | 32,763 (0%) | 0% | 48.3 | 136,990 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.04 per share. | 28 May 2020 | 18,453 | 35,601 (0%) | 0% | 0.0 | 738 | Common Stock |
Les Funtleyder | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 May 2020 | 18,453 | 0 | - | - | Stock Option (Right to Buy) | |
Les Funtleyder | Director | Sale of securities on an exchange or to another person at price $ 45.08 per share. | 28 May 2020 | 8,495 | 17,148 (0%) | 0% | 45.1 | 382,955 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 47.88 per share. | 13 May 2020 | 1,600 | 384,579 (2%) | 0% | 47.9 | 76,608 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 45.29 per share. | 13 May 2020 | 500 | 388,191 (2%) | 0% | 45.3 | 22,645 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 43.60 per share. | 13 May 2020 | 10,764 | 394,596 (2%) | 0% | 43.6 | 469,310 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 43.69 per share. | 13 May 2020 | 100 | 365,360 (1%) | 0% | 43.7 | 4,369 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 43.20 per share. | 13 May 2020 | 5,723 | 365,460 (1%) | 0% | 43.2 | 247,234 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 43.18 per share. | 13 May 2020 | 9,177 | 371,183 (2%) | 0% | 43.2 | 396,263 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 49.66 per share. | 13 May 2020 | 2,017 | 380,360 (2%) | 0% | 49.7 | 100,164 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 48.77 per share. | 13 May 2020 | 2,202 | 382,377 (2%) | 0% | 48.8 | 107,392 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 44.46 per share. | 13 May 2020 | 5,905 | 388,691 (2%) | 0% | 44.5 | 262,536 | Common Stock |
Joel S. Marcus | Director | Sale of securities on an exchange or to another person at price $ 46.61 per share. | 13 May 2020 | 2,012 | 386,179 (2%) | 0% | 46.6 | 93,779 | Common Stock |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 179,425 | 179,425 | - | - | Employee Stock Option (right to buy) | |
Adam Hansard | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2020 | 36,464 | 36,464 (0%) | 0% | 0 | Common Stock | |
Teena Lerner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2020 | 11,970 | 23,941 | - | - | Stock Option (right to buy) | |
Teena Lerner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.00 per share. | 06 Feb 2020 | 18,453 | 37,623 (0%) | 0% | 1 | 18,453 | Common Stock |
Teena Lerner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.70 per share. | 06 Feb 2020 | 11,970 | 49,593 (0%) | 0% | 4.7 | 56,259 | Common Stock |
Teena Lerner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2020 | 18,453 | 0 | - | - | Stock Option (right to buy) | |
Joel S. Marcus | Director | Purchase of securities on an exchange or from another person at price $ 45.50 per share. | 28 Jan 2020 | 500 | 405,360 (2%) | 0% | 45.5 | 22,750 | Common Stock |
Stacy J. Kanter | Director | Purchase of securities on an exchange or from another person at price $ 45.50 per share. | 28 Jan 2020 | 6,500 | 6,500 (0%) | 0% | 45.5 | 295,750 | Common Stock |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2019 | 221,377 | 1,492,094 (8%) | 1% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2019 | 221,377 | 3,304,285 (17%) | 1% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2019 | 80,000 | 3,525,662 (19%) | 0% | 0 | Common Stock | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2019 | 209,000 | 209,000 | - | - | Employee Stock Option (right to buy) | |
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2019 | 23,317 | 23,317 | - | - | Employee Stock Option (right to buy) | |
Riccardo Perfetti | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2019 | 80,000 | 80,000 | - | - | Employee Stock Option (right to buy) | |
Les Funtleyder | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2019 | 20,460 | 20,460 | - | - | Stock Option (right to buy) | |
Joel S. Marcus | Director | 16 May 2019 | 135,192 | 254,860 (1%) | 0% | - | Common Stock | ||
Joel S. Marcus | Director | 16 May 2019 | 135,192 | 0 | - | - | Series B Preferred Stock | ||
Joel S. Marcus | Director | 16 May 2019 | 110,497 | 0 | - | - | Series A Preferred Stock | ||
Joel S. Marcus | Director | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 16 May 2019 | 150,000 | 404,860 (2%) | 0% | 10 | 1,500,000 | Common Stock |
Joel S. Marcus | Director | 16 May 2019 | 110,497 | 119,668 (0%) | 0% | - | Common Stock | ||
Shoshana Shendelman | Director, President and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.00 per share. | 16 May 2019 | 125,000 | 3,605,662 (19%) | 0% | 10 | 1,250,000 | Common Stock |
Les Funtleyder | Director | 16 May 2019 | 3,314 | 12,485 (0%) | 0% | - | Common Stock | ||
Les Funtleyder | Director | 16 May 2019 | 1,325 | 13,810 (0%) | 0% | - | Common Stock | ||
Les Funtleyder | Director | 16 May 2019 | 3,314 | 0 | - | - | Series A Preferred Stock | ||
Les Funtleyder | Director | 16 May 2019 | 1,325 | 0 | - | - | Series B Preferred Stock | ||
Teena Lerner | Director | 16 May 2019 | 9,999 | 0 | - | - | Series B Preferred Stock | ||
Teena Lerner | Director | 16 May 2019 | 9,999 | 19,170 (0%) | 0% | - | Common Stock |